We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$578M
AUM Growth
+$21.8M
Cap. Flow
-$3.17M
Cap. Flow %
-0.55%
Top 10 Hldgs %
71.9%
Holding
76
New
5
Increased
14
Reduced
44
Closed
1

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.76M
2
GILD icon
Gilead Sciences
GILD
+$1.83M
3
VTRS icon
Viatris
VTRS
+$1.34M
4
XOM icon
ExxonMobil
XOM
+$1.17M
5
CAH icon
Cardinal Health
CAH
+$1.11M

Sector Composition

Rank Sector Weight
1 Financials 41.39%
2 Technology 16.55%
3 Energy 14.38%
4 Healthcare 13.57%
5 Consumer Staples 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
51
Illinois Tool Works
ITW
$81.1B
$621K 0.11%
2,370
SBR
52
Sabine Royalty Trust
SBR
$1.08B
$616K 0.11%
9,100
HP icon
53
Helmerich & Payne
HP
$4.11B
$571K 0.1%
15,777
+10,041
+175% +$388K
CFB
54
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$536K 0.09%
+39,500
New +$452K
CSX icon
55
CSX Corp
CSX
$96.5B
$523K 0.09%
15,083
ABT icon
56
Abbott
ABT
$199B
$482K 0.08%
4,375
-50
-1% -$5K
MCK icon
57
McKesson
MCK
$104B
$461K 0.08%
995
-515
-34% -$234K
PG icon
58
Procter & Gamble
PG
$337B
$414K 0.07%
2,825
-125
-4% -$18.5K
AXP icon
59
American Express
AXP
$227B
$403K 0.07%
2,150
SO icon
60
Southern Company
SO
$103B
$357K 0.06%
5,085
-390
-7% -$26.8K
UTHR icon
61
United Therapeutics
UTHR
$22.2B
$319K 0.06%
1,450
-125
-8% -$28.8K
CAT icon
62
Caterpillar
CAT
$379B
$310K 0.05%
1,050
MCD icon
63
McDonald's
MCD
$188B
$299K 0.05%
1,010
PM icon
64
Philip Morris
PM
$303B
$289K 0.05%
3,075
TSN icon
65
Tyson Foods
TSN
$20.1B
$274K 0.05%
5,096
+98
+2% +$4.76K
EFA icon
66
iShares MSCI EAFE ETF
EFA
$80B
$257K 0.04%
3,412
SYF icon
67
Synchrony
SYF
$26B
$250K 0.04%
6,550
-50
-0.8% -$1.58K
BMY icon
68
Bristol-Myers Squibb
BMY
$138B
$250K 0.04%
+4,865
New +$255K
SWKS icon
69
Skyworks Solutions
SWKS
$9.87B
$248K 0.04%
+2,207
New +$216K
ZBH icon
70
Zimmer Biomet
ZBH
$19.3B
$247K 0.04%
2,029
-66
-3% -$7.36K
WSBC icon
71
WesBanco
WSBC
$3.87B
$246K 0.04%
+7,845
New +$211K
MSFT icon
72
Microsoft
MSFT
$3.67T
$244K 0.04%
650
-50
-7% -$17.8K
WMB icon
73
Williams Companies
WMB
$90.9B
$232K 0.04%
6,650
-325
-5% -$11.4K
DWM icon
74
WisdomTree International Equity Fund
DWM
$694M
$227K 0.04%
4,319
T icon
75
AT&T
T
$177B
$174K 0.03%
+10,350
New +$163K

Similar funds

Greylin Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Greylin Investment Management held 76 positions worth $578M, up 3.9% from $557M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Greylin Investment Management's Q4 2023 filing shows 5 new, 14 increased, 44 reduced and 1 closed positions. Its largest new stake was CrossFirst Bankshares, Inc. Common Stock: 39,500 shares worth $536K. The largest sale was Alibaba, an estimated $3.76M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Technology and Energy.

  • Greylin Investment Management's largest Q4 2023 buy was CrossFirst Bankshares, Inc. Common Stock: 39,500 shares worth $536K.
  • Greylin Investment Management added most to Pfizer in Q4 2023, an estimated $4.7M increase.
  • Greylin Investment Management's biggest Q4 2023 reduction was Alibaba, cutting an estimated $3.76M.
  • Greylin Investment Management fully exited PayPal in Q4 2023, selling an estimated $890K.
  • Greylin Investment Management's ten largest holdings make up 72% of its $578M portfolio in Q4 2023.
  • Greylin Investment Management opened 5 new positions and closed 1 in Q4 2023.
  • Greylin Investment Management's portfolio value rose 3.9% quarter-over-quarter to $578M.

Based on Greylin Investment Management's 13F filing for Q4 2023, filed 26 Jan 2024.